Frontlight ResearchEarly access
Trial site
IEO Istituto Europeo di Oncologia
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer5 trials
- Lung cancer3 trials
- Melanoma3 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Prostate cancer2 trials
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Completed3 trials
- Terminated3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Daiichi Sankyo3 trials
- European Institute of Oncology2 trials
- Hoffmann-La Roche2 trials
- BioNTech SE1 trial
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)
Recruiting
Recruiting
Recruiting
Application of da Vinci SP for Endometrial Cancer Surgical Staging
Active, not recruiting
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Prostate cancer2 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Melanoma1 recruiting
Closed trials
Terminated
Withdrawn
Terminated
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026